Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-029788
Filing Date
2026-03-18
Accepted
2026-03-18 08:07:33
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 11750
2 POWER OF ATTORNEY ea028161903ex24-1.htm EX-24.1 16022
  Complete submission text file 0001213900-26-029788.txt   29264
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Issuer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INFLARX N.V. WINZERLAER STREET 2 JENA Germany 07745
Business Address
Fulpius Nicolas (Reporting) CIK: 0002115848 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38283 | Film No.: 26765518